Clinical study of s-ketamine in pediatric outpatient sedation

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200060976

Enrollment

Unknown

Registered

2022-06-14

Start date

2022-06-01

Completion date

Unknown

Last updated

2023-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pediatric outpatient sedation

Interventions

3:Different doses of s-ketamine nasal drops

Eligibility

Sex/Gender

All

Age

No minimum to 8 Years

Inclusion criteria

Inclusion criteria: Patients with clinical sedation who were classified as ASA grade ?-? and planned to undergo cardiac color doppler examination

Exclusion criteria

Exclusion criteria: The child was associated with chromosomal diseases, severe pulmonary hypertension, cyanosis and other manifestations before sedation, ASA grade ? or above, increased intracranial pressure, age (corrected gestational age) =3 months and weight =5kg

Design outcomes

Primary

Measure	Time frame
Ramsay sedation score;Steward awakening Score;	—

Secondary

Measure	Time frame
HR;SPO2;	—

Countries

P.R.China

Contacts

Public ContactDongjie Pei

jerrypei_16@hotmail.com15673227688

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026